News
GRTX
0.022
+4.76%
0.001
Weekly Report: what happened at GRTX last week (1222-1226)?
Weekly Report · 12/29/2025 09:34
Weekly Report: what happened at GRTX last week (1215-1219)?
Weekly Report · 12/22/2025 09:34
Weekly Report: what happened at GRTX last week (1208-1212)?
Weekly Report · 12/15/2025 09:37
Weekly Report: what happened at GRTX last week (1201-1205)?
Weekly Report · 12/08/2025 09:37
Weekly Report: what happened at GRTX last week (1124-1128)?
Weekly Report · 12/01/2025 09:35
Galera Therapeutics CEO Mel Sorensen Reports Sale of Common Shares
Reuters · 11/24/2025 21:43
Weekly Report: what happened at GRTX last week (1117-1121)?
Weekly Report · 11/24/2025 09:37
Weekly Report: what happened at GRTX last week (1110-1114)?
Weekly Report · 11/17/2025 09:38
Galera Therapeutics Q3 EPS $(0.01) Up From $(0.10) YoY
Benzinga · 11/13/2025 13:59
Weekly Report: what happened at GRTX last week (1103-1107)?
Weekly Report · 11/10/2025 09:36
Weekly Report: what happened at GRTX last week (1027-1031)?
Weekly Report · 11/03/2025 09:35
Galera Therapeutics Sells Assets to Biossil Inc.
TipRanks · 10/27/2025 12:03
Weekly Report: what happened at GRTX last week (1020-1024)?
Weekly Report · 10/27/2025 09:38
Biossil to acquire Galera’s dismutase mimetics portfolio for up to $105M
TipRanks · 10/22/2025 11:21
GALERA THERAPEUTICS ANNOUNCES ACQUISITION OF DISMUTASE MIMETICS PORTFOLIO BY TORONTO-BASED BIOSSIL FOR UP TO $105 MILLION
Reuters · 10/22/2025 11:00
Press Release: Galera Therapeutics Announces Acquisition of Dismutase Mimetics Portfolio by Toronto-based Biossil for up to $105 Million
Dow Jones · 10/22/2025 11:00
Galera Therapeutics Sells Assets to Biossil Inc.
TipRanks · 10/21/2025 20:33
Galera Therapeutics Sells Key Drug Assets to Biossil for Up to $108.5 Million
Reuters · 10/21/2025 20:06
Weekly Report: what happened at GRTX last week (1013-1017)?
Weekly Report · 10/20/2025 09:36
Weekly Report: what happened at GRTX last week (1006-1010)?
Weekly Report · 10/13/2025 09:37
More
Webull provides a variety of real-time GRTX stock news. You can receive the latest news about Galera Therapeutics, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About GRTX
Galera Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on advancing a pan-NOS inhibitor through clinical development for patients with the hardest-to-treat forms of advanced breast cancer.